Dergiler / Turkish Neurosurgery / 2016 / Cilt: 26 - Sayı: 4

Silk Device for the Treatment of Intracranial Aneurysms, Part 2: Factors Related to Clinical and Angiographic Outcome

Sayfa
533–537
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The futility of adjunctive coiling in this series calls for reappraisal of the current recommendations for this specific device.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:AIM: To report patient and procedure-related factors affecting the angiographic and clinical outcome in patients treated with the Silk device.
📊
Temel Bulgular & Veri:MATERIAL and METHODS: All patients with intracranial aneurysms in whom treatment was attempted with the Silk flow diverter by our neurovascular team between October 2010 and November 2013 were included consecutively.
💡
Sonuç & Katkı:The futility of adjunctive coiling in this series calls for reappraisal of the current recommendations for this specific device.
🔬Tür:Araştırma Makalesi
📍Kapsam:2010 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

AIM: To report patient and procedure-related factors affecting the angiographic and clinical outcome in patients treated with the Silk device. MATERIAL and METHODS: All patients with intracranial aneurysms in whom treatment was attempted with the Silk flow diverter by our neurovascular team between October 2010 and November 2013 were included consecutively. The data was analyzed by an independent stroke neurologist not involved in the treatment of the patients. RESULTS: A total of 96 patients (64 female) with ages range from 3 to 78 were included in this study. We found that 54 of the patients were asymptomatic and 42 of them symptomatic, while 21 had a prior history of subarachnoid hemorrhage (SAH). Mean aneurysm size was 10.2 mm (range 2 to 40 mm). 2 patients died due to consequences of SAH. 3 patients developed visual decline on the follow-up, 2 of these were procedure-related. Symptomatic thromboembolic events were noted in 7 cases. Patients with aneurysms smaller than 13 mm had significantly less complications and higher occlusion rates. The complication rate was significantly high in patients admitted with symptoms. Adjunctive coiling had no impact on outcome. CONCLUSION: Safety and efficacy of flow diversion in this series was closely related to aneurysm size and presenting symptoms. A size cut-off for safety and efficacy has not been reported before and will be useful not only for future studies but also for patient counseling in daily practice. The futility of adjunctive coiling in this series calls for reappraisal of the current recommendations for this specific device.

🔖

Bu Makaleye Atıf Yap

KAYA, T., DAĞLIOĞLU, E., GÜRKAS, E., AKMANGİT, İ., PEKER, A., BELEN, A. D., DEDE, D., ELHAN, A. H., ARAT, A. (2016). Silk Device for the Treatment of Intracranial Aneurysms, Part 2: Factors Related to Clinical and Angiographic Outcome. Turkish Neurosurgery, Cilt: 26 - Sayı: 4, 533–537. https://ajindex.com/articles/404695

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Briganti F, Napoli M, Tortora F, Solari D, Bergui M, Boccardi E, Cagliari E, Castellan L, Causin F, Ciceri E, Cirillo L, De Blasi R, Delehaye L, Di Paola F, Fontana A, Gasparotti R, Guidetti G, Divenuto I, Iannucci G, Isalberti M, Leonardi M, Lupo F, Mangiafico S, Manto A, Menozzi R, Muto M, Nuzzi NP, Papa R, Petralia B, Piano M, Resta M, Padolecchia R, Saletti A, Sirabella G, Bolgè LP: Italian multicenter experience with flow-diverter devices for intracranial unruptured aneurysm treatment with periprocedural complications-a retrospective data analysis. Neuroradiology 54(10):1145-1152, 2012 2. Byrne JV, Beltechi R, Yarnold JA, Birks J, Kamran M: Early experience in the treatment of intra-cranial aneurysms by endovascular flow diversion: A multicentre prospective study. PLoS One 5(9):pii: e12492,2010 3. Cohen JE, Gomori JM, Moscovici S, Leker RR, Itshayek E: Delayed complications after flow-diverter stenting: Reactive in-stent stenosis and creeping stents. J Clin Neurosci 21(7):1116-1122, 2014 4. Colombo A, Chieffo A: Drug-eluting stent update 2007: Part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation 116(12):1424-1432, 2007 5. D'Urso PI, Lanzino G, Cloft HJ, Kallmes DF: Flow diversion for intracranial aneurysms: A review. Stroke 42(8):2363-2368, 2011 6. Fiorella D, Lylyk P, Szikora I, Kelly ME, Albuquerque FC, McDougall CG, Nelson PK: Curative cerebrovascular reconstruction with the Pipeline embolization device: The emergence of definitive endovascular therapy for intracranial aneurysms. J NeuroIntervent Surg 1(1):56-65, 2009 7. Fiorella D, Woo HH, Albuquerque FC, Nelson PK: Definitive reconstruction of circumferential, fusiform intracranial aneurysms with the pipeline embolization device. Neurosurgery 62:1115-1120, 2008 8. Kallmes DF, Hanel R, Lopes D, Boccardi E, Bonafé A, Cekirge S, Fiorella D, Jabbour P, Levy E, McDougall C, Siddiqui A, Szikora I, Woo H, Albuquerque F, Bozorgchami H, Dashti SR, Delgado Almandoz JE, Kelly ME, Turner R 4th, Woodward BK, Brinjikji W, Lanzino G, Lylyk P: International retrospective study of the pipeline embolization device: A multicenter aneurysm treatment study. AJNR Am J Neuroradiol 36(1):108- 115, 2015 9. Kamran M, Yarnold J, Grunwald IQ, Byrne JV: Assessment of angiographic outcomes after flow diversion treatment of intracranial aneurysms: